NCT02685774View on ClinicalTrials.gov

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

April 30, 2016

Conditions
Diabetes Mellitus, Type II
Interventions
DRUG

Duvie Tab. 0.5mg, Glucophage XR Tab. 500mg

Duvie Tab. 0.5mg 1T, Glucophage XR Tab. 500mg 2T oral administration

DRUG

CKD-395 0.25/500mg

CKD-395 0.25/500mg 2T oral administration

Trial Locations (1)

Unknown

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY